Entera Bio (ENTX) Non-Current Assets (2017 - 2026)
Entera Bio (ENTX) reported Non-Current Assets of $584,000 for Q2 2026, up 64.0% from $356,000 a year earlier but down 8.2% from the prior quarter.
Powered by 
Analysis
Entera Bio (ENTX) Non-Current Assets (2017 - 2026) Analysis & Trends
At the end of FY2025, Entera Bio posted Non-Current Assets of $695,000, up 66.3% from FY2024.
- Non-Current Assets has a five-year compound annual growth rate of 2.5% (FY2020 to FY2025).
- By year, Non-Current Assets came in at $418,000 in FY2024 (-17.7%), $508,000 in FY2023 (+82.7%), $278,000 in FY2022 (-57.8%) and $658,000 in FY2021 (+7.3%).
- Five-year quarterly Non-Current Assets spans a low of $233,000 in Q1 2023 and a high of $695,000 in Q4 2025.
- Year over year, Non-Current Assets has now increased in each of the last three quarters, with growth averaging 13.9% over the last eight quarters.
- The high point for year-over-year Non-Current Assets in five years was Q1 2024 (growth of 109.4%); the low point was Q1 2023 (a decline of 65.3%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $636,000 (Q1 2026), $695,000 (Q4 2025) and $400,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 82.81 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 141.07 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 110.20 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 75.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 88.47 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 61.69 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 34.86 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 159.99 Bn |
| 10 | Entera Bio | 563.51 Mn | 269.58 Mn | - | 575,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 575,000.00 |
| Jun 30, 2026 | 584,000.00 |
| Mar 31, 2026 | 636,000.00 |
| Dec 31, 2025 | 695,000.00 |
| Sep 30, 2025 | 400,000.00 |
| Jun 30, 2025 | 356,000.00 |
| Mar 31, 2025 | 382,000.00 |
| Dec 31, 2024 | 418,000.00 |
| Sep 30, 2024 | 401,000.00 |
| Jun 30, 2024 | 440,000.00 |
| Mar 31, 2024 | 488,000.00 |
| Dec 31, 2023 | 508,000.00 |
| Sep 30, 2023 | 549,000.00 |
| Jun 30, 2023 | 631,000.00 |
| Mar 31, 2023 | 233,000.00 |
| Dec 31, 2022 | 278,000.00 |
| Sep 30, 2022 | 350,000.00 |
| Jun 30, 2022 | 662,000.00 |
| Mar 31, 2022 | 671,000.00 |
| Dec 31, 2021 | 658,000.00 |
API Access
Entera Bio Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=ENTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "ENTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=ENTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();